Firm
Practitioners say the UK Supreme Court’s decision could boost the attractiveness of the UK for AI companies
In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in inventive step analyses
Public figures are turning to trademark protection to combat the threat of AI deepfakes and are monetising their brand through licensing deals, a trend that law firms are keen to capitalise on
Tom Melsheimer, part of a nine-partner team to join King & Spalding from Winston & Strawn, says the move reflects Texas’s appeal as a venue for high-stakes patent litigation
Sponsored
Sponsored
-
Sponsored by Wanhuida Intellectual PropertyAs an AstraZeneca patent survives a tenth invalidation challenge in China, Jianhui Li of Wanhuida Intellectual Property considers the implications for generic drug makers and the pharmaceutical industry -
Sponsored by Tilleke & GibbinsSuebsiri Taweepon of Tilleke & Gibbins highlights a critical issue in Thailand’s copyright regime while examining the legal uncertainties, licensing burdens, and data-scraping risks in AI development
-
Sponsored by Patrinos & KilimirisMaria Kilimiris of Patrinos & Kilimiris says the decision on the ‘Belvedere Mykonos Club’ mark highlights the importance of complementary goods and services as a factor in opposition cases
-
Sponsored by Cabinet M OproiuIn this opening article of a series, Raluca Vasilescu of Cabinet M Oproiu explains her conclusions after experimenting with various AI assistants when responding to office actions in patent applications
-
Sponsored by Remfry & SagarSonal Goel of Remfry & Sagar says two recent rulings show Indian courts’ evolving approach to tackling online counterfeiting, impersonation, and trademark misuse through dynamic, dynamic+, and superlative injunctions
-
Sponsored by Bugnion SpAAndrea Delbarba and Claudia Finetti of Bugnion SpA explain how supplementary protection certificates extend pharmaceutical patent protection, the role of paediatric extensions, and recent Italian clarifications on fees and regulatory processes
